#United States #Astrana Health #Alhambra #NASDAQ: ASTH #healthcare improvements

Astrana Health, Inc. Reports Outstanding Second Quarter Results for 2026

In a significant announcement made on August 6, 2026, Astrana Health, Inc. (NASDAQ: ASTH) revealed its financial results for the second quarter ended June 30, 2026. The company, known for its physician-centric and technology-enabled healthcare system, reported a total revenue of $972.5 million, marking a 49% increase year-over-year. This performance underscores the company's robust growth trajectory and commitment to providing accessible healthcare.

Brandon Sim, President and CEO of Astrana, expressed satisfaction with the results, highlighting the efficacy of Astrana's AI-powered operating system and the team's disciplined execution. He remarked, "We continue to see accelerating demand from both providers and payers for our platform, driving strong growth, record-high adjusted diluted EPS, and robust free cash flow generation."

Financial Highlights

The financial highlights for the second quarter reflect significant growth in multiple areas:

• - Net Income: Reached $18.5 million, an 81% increase compared to the previous year.
• - Adjusted EBITDA: Averaged $68.9 million, marking a growth of 43% year-over-year.
• - Adjusted Earnings Per Share (EPS): Increased to $0.80, a 45% rise compared to last year.
• - Free Cash Flow: Recorded at $92.9 million for the first half of 2026.

For the six months ending June 30, 2026, Astrana reported a total revenue of $1,937.6 million, an impressive 52% increase from $1,275.2 million in 2025. The continued rise in revenues is attributed to Astrana’s innovative healthcare solutions and strong performance in care partnerships.

Expanding Leadership and Operations

Recently, Astrana made significant strides in strengthening its leadership team. Daniel Rothman was appointed as the President of Physician Enterprise, and Vishal Gupta joined as the Senior Vice President of Enterprise Transformation, driving further growth in their physician-centric model.

Additionally, Astrana’s affiliated Accountable Care Organizations (ACOs) achieved $120.4 million in gross shared savings for the 2024 performance year, showcasing the effectiveness of its care models. As part of expanding its services, Astrana has also broadened its Medicare Advantage footprint with new agreements in regions such as Hawaii and Texas, further enhancing its outreach and capabilities in the healthcare sector.

Looking Ahead

Given the strong performance in the second quarter, Astrana has adjusted its guidance for the upcoming quarters. The company anticipates a total revenue of $1 billion to $1.03 billion for the third quarter of 2026, with an expected Adjusted EBITDA ranging from $72.5 million to $77.5 million.

The management remains optimistic about continued growth, particularly as they reinvest in attractive opportunities. Sim believed the ongoing investments would enhance Astrana's earning power in the long term.

Conclusion

Astrana Health, Inc. has firmly established itself as a leader in the healthcare sector with its innovative and effective solutions. As it continues to expand its services and operational capabilities, the future looks promising for both the organization and the patients it serves. With a solid financial footing and an eye on growth, Astrana is poised to reshape the landscape of healthcare services.

For more information about Astrana Health, visit Astrana Health.